1951 - 1960 of 6230 Results
Title
Year
-
OPENTitle: LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosomeJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00880-7Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00880-7Citation Count: 0
- Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort2022OPENTitle: Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohortJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-022-00964-1Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-022-00964-1Citation Count: 32
-
OPENTitle: Clinical progression and genetic pathways in body-first and brain-first Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00866-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00866-5Citation Count: 0
- Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study2023OPENTitle: Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort studyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-023-02843-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/s12974-023-02843-5Citation Count: 25
- Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances2024OPENTitle: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbancesJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12916-024-03766-5Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12916-024-03766-5.pdfCitation Count: 1
- Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls2023OPENTitle: Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controlsJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12916-023-02994-5Best OA location URL: https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-023-02994-5Citation Count: 7
-
OPENTitle: APOE contributes to longitudinal impulse control disorders progression in Parkinson’s diseaseJournal Name: BMC PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12888-024-06084-5Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12888-024-06084-5.pdfCitation Count: 0
- Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease2024OPENTitle: Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03642-yBest OA location URL: https://link.springer.com/content/pdf/10.1186/s12883-024-03642-y.pdfCitation Count: 6
-
OPENTitle: Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohortJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01777-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01777-2Citation Count: 18
- Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease2023OPENTitle: Association of polygenic risk score with response to deep brain stimulation in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03188-5Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03188-5Citation Count: 4